Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ozanimod, an S1PR1 ligand, attenuates hypoxia plus glucose deprivation-induced autophagic flux and phenotypic switching in human brain VSM cells.
Am J Physiol Cell Physiol. 2021 Jun 1;320(6):C1055-C1073. doi: 10.1152/ajpcell.00044.2021. Epub 2021 Mar 31.
Am J Physiol Cell Physiol. 2021.
PMID: 33788630
Free article.
Ozanimod differentially preserves human cerebrovascular endothelial barrier proteins and attenuates matrix metalloproteinase-9 activity following in vitro acute ischemic injury.
Wendt TS, Gonzales RJ.
Wendt TS, et al.
Am J Physiol Cell Physiol. 2023 Oct 1;325(4):C951-C971. doi: 10.1152/ajpcell.00342.2023. Epub 2023 Aug 29.
Am J Physiol Cell Physiol. 2023.
PMID: 37642239
Item in Clipboard
LOX-1 and MMP-9 Inhibition Attenuates the Detrimental Effects of Delayed rt-PA Therapy and Improves Outcomes After Acute Ischemic Stroke.
Arkelius K, Wendt TS, Andersson H, Arnou A, Gottschalk M, Gonzales RJ, Ansar S.
Arkelius K, et al. Among authors: wendt ts.
Circ Res. 2024 Apr 12;134(8):954-969. doi: 10.1161/CIRCRESAHA.123.323371. Epub 2024 Mar 19.
Circ Res. 2024.
PMID: 38501247
Free article.
Item in Clipboard
Cite
Cite